A Case of Plasma Cell Leukemia Arising De Novo: A Rare and Fatal Disease.

clinical hematology cytology and hematology hematology laboratory malignant hematology multiple myelomam plasma cell leukaemia practicing internal medicine

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Oct 2024
Historique:
accepted: 13 10 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Plasma cell leukemia (PCL) is an aggressive form of multiple myeloma characterized by an increasing number of circulating plasma cells in the peripheral (circulating) blood. Primary PCL (pPCL) is the form of monoclonal gammopathy that is the most severe with a high mortality rate. Its incidence will be increasing, given the expected changes in clinical criteria for diagnosis. We present a case to help further understand the disease and the proposed criteria changes, as more research will be needed to better understand the impact of specific genetic findings on the prognosis of pPCL and secondary PCL (sPCL). We also feature the presentation, morphological changes in the peripheral smear, and cytogenetics of this rare disease.

Identifiants

pubmed: 39403422
doi: 10.7759/cureus.71393
pmc: PMC11471913
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e71393

Informations de copyright

Copyright © 2024, Sweidan et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Hisham B Sweidan (HB)

Internal Medicine, Detroit Medical Center (DMC) Sinai Grace Hospital, Detroit, USA.

Abdullah Jarrah (A)

Internal Medicine, Detroit Medical Center (DMC) Sinai Grace Hospital, Wayne State University, Detroit, USA.

Feng Zhu (F)

Internal Medicine, Detroit Medical Center (DMC) Sinai Grace Hospital, Wayne State University, Detroit, USA.

Yating Wang (Y)

Hematology and Oncology, Ascension Providence Hospital, South Field, USA.

Classifications MeSH